Janus Henderson Group PLC Grifols Sa Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Grifols Sa stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,720,391 shares of GRFS stock, worth $21.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,720,391

Previous 3,261,763 16.6%

Holding current value

$21.3 Million

Previous $20.5 Million 17.56%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $9.38 $3.4 Million - $5.08 Million	-541,372 Reduced 16.6%	2,720,391 $24.2 Million
Q2 2024 Aug 14, 2024	BUY	$6.27 - $7.7 $11.1 Million - $13.6 Million	1,771,389 Added 118.86%	3,261,763 $20.5 Million
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $1.79 Million - $3.72 Million	-327,100 Reduced 18.0%	1,490,374 $9.96 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $3.32 Million - $4.97 Million	-430,354 Reduced 19.15%	1,817,474 $21 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $24,876 - $30,460	2,792 Added 0.12%	2,247,828 $20.5 Million
Q2 2023 Aug 14, 2023	SELL	$7.14 - $9.29 $490,725 - $638,492	-68,729 Reduced 2.97%	2,245,036 $20.6 Million
Q1 2023 May 15, 2023	SELL	$6.65 - $10.69 $884,150 - $1.42 Million	-132,955 Reduced 5.43%	2,313,765 $17.1 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $1.07 Million - $1.53 Million	179,888 Added 7.94%	2,446,720 $20.8 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $11 Million - $26.4 Million	-1,848,366 Reduced 44.92%	2,266,832 $13.9 Million
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $2.06 Million - $2.58 Million	194,360 Added 4.96%	4,115,198 $48.9 Million
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $15.4 Million - $19 Million	-1,489,713 Reduced 27.53%	3,920,838 $45.8 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $6.7 Million - $10 Million	655,869 Added 13.79%	5,410,551 $60.8 Million
Q3 2021 Nov 16, 2021	BUY	$14.07 - $17.3 $4.44 Million - $5.46 Million	315,440 Added 7.11%	4,754,682 $69.5 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $12.2 Million - $13.9 Million	733,556 Added 19.8%	4,439,242 $77 Million
Q1 2021 May 17, 2021	BUY	$15.15 - $19.78 $4.65 Million - $6.07 Million	306,655 Added 9.02%	3,705,686 $64.1 Million
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $477,778 - $557,408	-28,338 Reduced 0.83%	3,399,031 $62.6 Million
Q3 2020 Nov 16, 2020	SELL	$15.4 - $20.16 $347,993 - $455,555	-22,597 Reduced 0.65%	3,427,369 $59.5 Million
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $10.5 Million - $12.3 Million	-573,258 Reduced 14.25%	3,449,966 $63 Million
Q1 2020 May 14, 2020	BUY	$16.28 - $25.63 $27.1 Million - $42.6 Million	1,662,872 Added 70.45%	4,023,224 $80.6 Million
Q4 2019 Feb 18, 2020	BUY	$19.57 - $23.52 $24.6 Million - $29.5 Million	1,254,476 Added 113.44%	2,360,352 $55 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $1.42 Million - $1.63 Million	71,578 Added 6.92%	1,105,876 $22.2 Million
Q2 2019 Jul 31, 2019	BUY	$17.59 - $21.1 $1.86 Million - $2.23 Million	105,562 Added 11.37%	1,034,298 $21.8 Million
Q1 2019 Apr 30, 2019	BUY	$18.01 - $20.11 $2.75 Million - $3.07 Million	152,417 Added 19.63%	928,736 $18.7 Million
Q4 2018 Feb 06, 2019	BUY	$17.44 - $21.53 $2.06 Million - $2.54 Million	118,117 Added 17.95%	776,319 $14.2 Million
Q3 2018 Nov 09, 2018	SELL	$19.97 - $21.96 $4.66 Million - $5.12 Million	-233,347 Reduced 26.17%	658,202 $14.1 Million
Q1 2018 May 14, 2018	SELL	$20.31 - $24.95 $4.19 Million - $5.15 Million	-206,236 Reduced 18.79%	891,549 $18.9 Million
Q4 2017 Feb 09, 2018	SELL	$20.99 - $23.89 $5.17 Million - $5.89 Million	-246,351 Reduced 18.33%	1,097,785 $25.2 Million
Q2 2017 Aug 17, 2017	BUY	N/A	1,344,136	1,344,136 $28.4 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Grifols Sa Transaction History